Aug 15, 2018
Suma M. Krishnan, Founder and COO, Krystal Biotech discusses their approach to treating rare genetic skin diseases that lack any truly effective treatments. Krystal is developing the first ever topically applied gene therapy for the rare disease epidermolysis, a genetic condition characterized by extremely fragile skin that leads to devastating physical developments. Krystal is looking to apply their novel gene therapy to treat a wide range of skin conditions for those of all ages.
#RareDisease #EpidermolysisBullosa #Ichthyosis #GeneTherapy #Dermatology #FightEB #IchthyosisAwareness